Shionogi Canada reply
16 November 2026 · 8:57 a.m. EST
From: Andy Zylak, General Manager, Shionogi Canada Inc.
To: Long COVID Action Canada
Subject: Response to Long COVID Action Canada Inquiry regarding Ensitrelvir
About this transcript and redactions
Reformatted public transcript of the reply body received in Fastmail. Email addresses, phone numbers, the office address and the website link in the signature are omitted. Routing headers are not included. The reply wording is unchanged.
Reply
Dear Mr. DeRosa,
Thank you for reaching out to Shionogi Canada Inc. and for sharing the perspectives of Long COVID Action Canada. We appreciate your dedicated advocacy on behalf of patients and families across the country.
At Shionogi, our foundational philosophy is to supply the best possible medicine to protect the health and wellbeing of the patients we serve. In Canada, we are united in our mission to address significant unmet medical needs and positively impact patient lives.
Guided by this philosophy, we recognize the ongoing burden of COVID-19 and long COVID and the importance of continued scientific innovation. Shionogi remains deeply committed to Canadian patients, and we are actively exploring options and potential pathways for ensitrelvir in Canada. We continuously assess emerging research and value open, constructive dialogue with the patient community.
We would value hearing more about the experiences, needs and perspectives of people living with Long COVID in Canada, and learning from the insights you have gained through your work supporting and advocating for this community.
Thank you once again for bringing forward your community’s voice. We have shared your letter with our internal teams and are carefully considering the points you raised. We will follow up once this assessment is complete and anticipate providing a further update in the coming months. We appreciate your patience.
Andy Zylak
General Manager | Canada
Shionogi Canada Inc.
What happens next: LCAC will reply to Shionogi Canada and ask when its fuller response will come. See LCAC’s next steps and tell us what you think.